Primary Cell and Tissue Dissociation: Matching the Enzyme to the Tissue

Tissue dissociation enzyme selection is governed by the extracellular matrix you have to break down, not by the cell you want to collect. A protease that releases an adherent monolayer in three minutes will barely dent collagen-rich tumour stroma, and a collagenase blend that liberates adipocytes will leave a neural aggregate intact.

This guide maps the main enzyme classes onto the tissues they are used for, sets out the trade-offs on yield, viability and surface epitopes, and describes how to validate a dissociation protocol in your own material.

Tissue Dissociation Enzyme Selection Starts With the Matrix, Not the Cell

Getting a single-cell suspension out of solid tissue requires three things to happen together: mechanical dissection, enzymatic degradation of the extracellular matrix, and enough gentleness that the cells and the antigens you need survive the process. The reference treatment of this for flow cytometry sets the problem out plainly — cells and the extracellular matrix contain a range of proteins and structures that all have to be considered when designing a digestion, because the goal is to cleave matrix components and cell–cell junctions while preserving viability and the relevant antigens (Reichard & Asosingh, Cytometry Part A 2019).

So the first question is not "which enzyme is best" but "what is holding this tissue together". Fibrillar collagen, basement-membrane collagen IV and laminin, elastin, hyaluronan, and cadherin-based cell–cell junctions are different substrates and need different enzymes. Most working protocols use a blend for exactly this reason.

The Main Enzyme Classes and What Each One Cuts

Matching the Enzyme to the Tissue

The starting points below are conventional in the field and are intended as orientation, not as validated protocols. Every one of them needs to be titrated for species, age of animal, tissue state and the downstream readout.

• Solid tumour and tumour stroma — collagenase-based blend, usually with DNase I. Necrotic material raises free-DNA release and makes DNase I effectively mandatory.
• Adipose (stromal vascular fraction) — collagenase, followed by density separation rather than further enzymatic work.
• Liver — collagenase perfusion where the anatomy allows it; the perfusion, not the enzyme alone, does most of the work.
• Lung — collagenase plus elastase, kept short; lung is a mixed-matrix tissue and no single enzyme covers it.
• Skin and other stratified epithelia — dispase to split epidermis from dermis, then a trypsin-like enzyme on the separated epithelial sheet.
• Intestinal epithelium and organoids — chelation (EDTA) to release crypts, then a brief trypsin-like or gentler enzymatic step to reach single cells.
• Neural tissue and neurospheres — papain, with trituration doing a large share of the dissociation.
• Bone marrow and blood-derived material — usually no matrix enzyme at all; mechanical and density methods suffice.

Temperature, Time and Mechanical Force Are Part of the Enzyme Choice

Enzyme identity is only one of the variables, and often not the dominant one. A systematic comparison of dissociation and storage workflows in adult mouse kidney found that digestion on ice avoided the stress response seen with 37 °C dissociation, and — importantly — that warm and cold protocols recovered different cell types in different proportions, suggesting some populations need harsher conditions to be released intact while others are destroyed by them (Denisenko et al., Genome Biology 2020).

The same study found that cryopreserving dissociated cells caused a major loss of epithelial cell types, while methanol fixation preserved the composition but allowed ambient RNA leakage. In other words, the storage decision can undo a well-chosen enzyme.

Cold-active proteases have become the standard mitigation where transcriptional fidelity is the priority. Dissociating zebrafish tendon and ligament in subtilisin A at 4 °C, versus collagenase at 37 °C, reduced general stress signatures and preserved expression of hallmark tenocyte specification and matrix genes (Subramanian et al., Bio-protocol 2025). The underlying artefact — a reproducible immediate-early gene programme induced by the isolation itself — was characterised in tissue single-cell data by van den Brink et al., Nature Methods 2017, and the mitigation options are reviewed in Machado et al., Trends in Cell Biology 2021.

Practical consequence: if your endpoint is transcriptomic, treat temperature as a first-class design decision. If your endpoint is a functional assay or establishing a culture, a warm, faster digestion is usually the better trade.

Trypsin-Like Enzymes in Primary Work: What They Do and Do Not Do

A trypsin-like serine protease is rarely the primary matrix enzyme in tissue dissociation. Its usual jobs are narrower and worth stating clearly:

• Releasing primary cells from the plate once they have been established in adherent culture.
• Breaking residual cell–cell junctions and small clumps after the matrix has already been digested.
• Passaging a primary culture without introducing an animal-derived raw material into the workflow.

Exposure time is the controlling variable for epitope loss. In human synovial mesenchymal stromal cells, trypsin significantly reduced CD44+, CD55+, CD73+, CD105+, CD140a+, CD140b+ and CD201+ cell numbers within 30 minutes, while a recombinant trypsin-like reagent did not measurably affect any of the antigens tested at the same time point, and collagenase reduced CD140a by 30 minutes (Tsuji et al., Cell Transplantation 2017). That is a single cell source and a stem-cell antigen panel; it is not a general guarantee for your marker. It does establish the direction of the effect and the timescale on which it operates.

Where CellTrypase Fits in a Primary Workflow — and Where the Data Stops

CellTrypase from Kerry (formerly c-LEcta) is a recombinant trypsin-like serine protease, approximately 22 kDa, cleaving after lysine and arginine. The gene is from Fusarium oxysporum and is expressed in a Bacillus sp. host (GMO safety level S1). It is supplied in PBS with 1.1 mM EDTA, sterile filtered, at pH 7.1–7.6 and 270–320 mOsm/kg, with purity ≥95% by HPLC and activity of 0.6–1.2 kU/L at 1x. Endotoxin is ≤1 EU/mL (1x), the product is mycoplasma negative and passes sterility testing to Ph. Eur. 2.6.1 / USP <71>. It is animal-origin-free (TSE/BSE-free); the GMP grade is manufactured under EXCiPACT® GMP/GDP and the R&D grade under ISO 9001:2015. Stated stability is at least 21 months at 2–8 °C, with long-term stability beyond that window still under investigation by the manufacturer.

For primary and tissue work the animal-origin-free status is the substantive point. It removes one animal-derived raw material from the workflow, along with the sourcing documentation that comes with it.

What we will not tell you is how it performs on your tissue, because that data does not exist. The manufacturer's performance dataset stops at four established cell lines and human iPSC. The figures for the four lines are:

Source: CellTrypase Product Information Sheet v4.0 (Kerry, 18 August 2026). Note the MDCK result openly: 23 minutes 32 seconds, roughly ten times the CHO-K1 release time, with viability and yield preserved. Tight epithelial junctions take longer to release. That is directly relevant if you work with primary epithelial cultures.

Kerry has since published five-passage data (P0–P4) for these same four lines — viability, relative yield and population doubling time — in which doubling times were equal to or shorter than the industry-standard control on all four, so proliferation is maintained over serial passaging rather than merely assumed. Source: Kerry scientific poster #11462, "Advancing cell dissociation in bioprocessing with CellTrypase" (February 2026); n = 3 technical replicates, mean ± SD.

Human iPSC is the one stem-cell application that now carries published figures — 2D colonies and 3D iPSC aggregates, with dissociation time, viability, relative yield, residual aggregates and a flow-cytometry pluripotency panel, all from the same poster — but none of it speaks to tissue.

Published comparative data covers CHO-K1, HEK 293, MDCK, Vero and human iPSC in 2D and 3D, and stops there. Primary cells, organoids and human embryonic stem cells are named by the manufacturer as intended applications but carry no published performance data; neurons, mesenchymal stromal cells, T cells, cardiomyocytes and retinal pigment epithelium are not on that list at all, and carry no data. No viability, yield, recovery, marker-retention or pluripotency figure exists on file for those other cell types, and we are not going to invent one. If you need that number, generate it: a free 100 mL evaluation unit runs a proper side-by-side against your current reagent. Request an evaluation unit.

Two handling notes that do apply generally: the 1x concentration is appropriate for most applications, dosed at approximately 1 mL per 25 cm² of growth area and pre-warmed to room temperature or 37 °C; and no trypsin inhibitor is needed, because dilution in buffer or medium is sufficient to stop the reaction. The reagent can be dosed 1:1 in place of a 1x trypsin-like reagent in your existing protocol — but verify detachment time and viability in your own cell model before switching.

Validating a Dissociation Protocol in Your Own Tissue

Whatever enzyme you choose, the acceptance criteria are the same, and they should be written down before the first digestion:

• Viability of the suspension immediately after dissociation and again after any storage step. High viability and low debris are prerequisites for flow cytometry and for droplet-based single-cell workflows (Reichard & Asosingh 2019).
• Yield per gram of tissue, not just per digestion. Yield per gram is the number that transfers between experiments.
• Cell-type composition. If a population you expect is missing, suspect the enzyme or the temperature before you suspect the biology — warm and cold protocols recover different populations from the same tissue.
• Antigen retention for every marker in your panel, checked immediately after dissociation. Cleaved epitopes often recover after a rest in complete medium; destroyed ones do not.
• Dissociation stress signature, if the endpoint is transcriptomic. Score the immediate-early gene set rather than assuming your protocol is clean.
• Aggregate and debris fraction before loading anything into a microfluidic device.

One process note for regulated work: changing a raw material in a qualified process is a change-control decision that sits with you. A supplier's animal-origin-free or GMP documentation supports that assessment; it does not replace it.

Related reading: CellTrypase specifications and comparison, the CellTrypase cell dissociation protocol, and the cell lines and primary cells collection.

References

1. Reichard A, Asosingh K. Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry. Cytometry Part A 2019;95(2):219–226. doi:10.1002/cyto.a.23690
2. Denisenko E, Guo BB, Jones M, et al. Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows. Genome Biology 2020;21(1):130. doi:10.1186/s13059-020-02048-6
3. van den Brink SC, Sage F, Vértesy Á, et al. Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations. Nature Methods 2017;14(10):935–936. doi:10.1038/nmeth.4437
4. Machado L, Relaix F, Mourikis P. Stress relief: emerging methods to mitigate dissociation-induced artefacts. Trends in Cell Biology 2021;31(11):888–897. doi:10.1016/j.tcb.2021.05.004
5. Subramanian A, Nayak PK, Schilling TF. A Cold-Active Protease Tissue Dissociation Protocol for the Preservation of the Tendon Fibroblast Transcriptome. Bio-protocol 2025;15(9):e5293. doi:10.21769/BioProtoc.5293
6. Tsuji K, Ojima M, Otabe K, et al. Effects of Different Cell-Detaching Methods on the Viability and Cell Surface Antigen Expression of Synovial Mesenchymal Stem Cells. Cell Transplantation 2017;26(6):1089–1102. doi:10.3727/096368917X694831
7. c-LEcta GmbH (a Kerry company). CellTrypase Product Information Sheet, Version 4.0, valid as of 18 August 2026.
8. Kerry. Advancing cell dissociation in bioprocessing with CellTrypase. Scientific poster #11462, February 2026.

Bibliographic records for references 1–6 were retrieved from PubMed.

TrypLE™ is a trademark of Thermo Fisher Scientific Inc. Any reference to it here is nominative — used only to identify a widely used reagent class — and implies no affiliation with, sponsorship by, or endorsement from Thermo Fisher Scientific Inc. CellTrypase R&D grade (SKU 22103-1X-100) is for research use only; not for use in diagnostic or therapeutic procedures. A GMP grade (22103-1X-100-G) is available separately.